All News

As fears of the Ebola virus and other infectious diseases rise, pharmacists will undoubtedly be called upon to provide patients with public health information and referrals to appropriate care, according to the American Pharmacists Association.

FDA approved two new therapies for idiopathic pulmonary fibrosis (IPF): pirfenidone (Esbriet, Roche) and nintedanib (Ofev, Boehringer Ingelheim). Both drugs are orally administered and will help slow the progression of IPF.

The Iowa Board of Pharmacy is forcing the owner of several pharmacies to sell or close them partially because he failed to notice that an employee stole 18,000 hydrocodone tablets over two years.

FDA last week approved Harvoni (ledipasvir and sofosbuvir), a daily pill to treat hepatitis C virus (HCV) that reportedly costs $1,125 per pill.

HIPAA in Wonderland

In which a determined pharmacist battles the forces of ignorance and stupidity on behalf of his patient and his own sanity.

Patients should decide how a pharmacy can best communicate with patients. And they can use a very American way to make their feelings known.

The National Community Pharmacists Association (NCPA) strongly opposes a Pennsylvania bill that would only allow biosimilar substitution by a pharmacy with permission of the prescriber.

Following the 2012 fungal meningitis outbreak that killed 64 people and sickened hundreds, FDA tightened regulations on compounders like the New England Compounding Center in Massachusetts to which the tainted drugs were linked.